Cardiovascular diseases burden in COVID-19

Am J Emerg Med. 2021 Dec:50:790. doi: 10.1016/j.ajem.2021.09.066. Epub 2021 Oct 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cardiovascular Diseases* / epidemiology
  • Cost of Illness
  • Heparin
  • Humans
  • SARS-CoV-2

Substances

  • Heparin